Quantum-Enhanced Drug Screening Platform Cuts Years from Cancer Drug Development
Summary:
A partnership between IBM and Moderna, Inc. has launched a quantum computing platform that simulates molecular interactions 10,000 × faster, enabling new cancer-drug candidates in weeks instead of years.
5 responses to “Quantum-Enhanced Drug Screening Platform Cuts Years from Cancer Drug Development”
Nicholas
One of the questions I have about these breakthroughs is whether we will be able to take advantage or whether we will destroy/incapacitate our societies before we get a chance to make these technologies commercially viable and integrate them into the supply chain.
Yes – and perhaps these developments are (part of) how the world will be transformed in the Millennium into an age when longevity is greater than it is now by several multiples.
Yeah, if we don’t destroy the world before it comes to fruition. I guess we need to hope for the best because it isn’t going to stop the advances that we are seeing
Loading…
Nicholas
Hope springs eternal, as they say. But it will require people with proper morals to implement – otherwise we are headed for exploitation and conflict
The procedure, called ventriculo-coronary transcatheter outward navigation and re-entry, or VECTOR, creates a new route for blood flow that is a safe distance away from the aortic valve.
Engineers have built the smallest fully autonomous robots yet, capable of sensing, computing, and acting on their own at microscopic scales, with potential applications in medicine and manufacturing.
Through the genome-wide data of 26 ancient human remains from northern and southern East Asia, spanning 9,500 to 300 years ago, including some extracted from the Qihedong skull, they carried out a series of scientific analyses that supported a southern China origin for proto-Austronesians.
The findings trace the long history of HHV-6 integration into human chromosomes and suggest that HHV-6A lost this ability early on... trace the viruses' evolution can now be traced over more than 2,500 years across Europe, using genomes from the 8th-6th century BCE until today.
Scientists have identified two new biological subtypes of multiple sclerosis using AI, blood biomarkers, and MRI scans. The discovery could lead to more accurate diagnoses and personalized treatments based on how the disease damages the nervous system.
Discover more from Changing Knowledge
Subscribe now to keep reading and get access to the full archive.
Leave a Reply to NicholasCancel reply